1 Dolutegravir/Rilpivirine Combination Drug Market Overview 1.1 Dolutegravir/Rilpivirine Combination Drug Product Overview 1.2 Dolutegravir/Rilpivirine Combination Drug Market Segment by Type 1.2.1 Self-production API 1.2.2 Outsourcing of API 1.3 Global Dolutegravir/Rilpivirine Combination Drug Market Size by Type 1.3.1 Global Dolutegravir/Rilpivirine Combination Drug Market Size Overview by Type (2016-2027) 1.3.2 Global Dolutegravir/Rilpivirine Combination Drug Historic Market Size Review by Type (2016-2021) 1.3.2.1 Global Dolutegravir/Rilpivirine Combination Drug Sales Breakdown in Volume by Type (2016-2021) 1.3.2.2 Global Dolutegravir/Rilpivirine Combination Drug Sales Breakdown in Value by Type (2016-2021) 1.3.2.3 Global Dolutegravir/Rilpivirine Combination Drug Average Selling Price (ASP) by Type (2016-2021) 1.3.3 Global Dolutegravir/Rilpivirine Combination Drug Forecasted Market Size by Type (2022-2027) 1.3.3.1 Global Dolutegravir/Rilpivirine Combination Drug Sales Breakdown in Volume by Type (2022-2027) 1.3.3.2 Global Dolutegravir/Rilpivirine Combination Drug Sales Breakdown in Value by Type (2022-2027) 1.3.3.3 Global Dolutegravir/Rilpivirine Combination Drug Average Selling Price (ASP) by Type (2022-2027) 1.4 Key Regions Market Size Segment by Type 1.4.1 North America Dolutegravir/Rilpivirine Combination Drug Sales Breakdown by Type (2016-2021) 1.4.2 Europe Dolutegravir/Rilpivirine Combination Drug Sales Breakdown by Type (2016-2021) 1.4.3 Asia-Pacific Dolutegravir/Rilpivirine Combination Drug Sales Breakdown by Type (2016-2021) 1.4.4 Latin America Dolutegravir/Rilpivirine Combination Drug Sales Breakdown by Type (2016-2021) 1.4.5 Middle East and Africa Dolutegravir/Rilpivirine Combination Drug Sales Breakdown by Type (2016-2021) 2 Global Dolutegravir/Rilpivirine Combination Drug Market Competition by Company 2.1 Global Top Players by Dolutegravir/Rilpivirine Combination Drug Sales (2016-2021) 2.2 Global Top Players by Dolutegravir/Rilpivirine Combination Drug Revenue (2016-2021) 2.3 Global Top Players Dolutegravir/Rilpivirine Combination Drug Price (2016-2021) 2.4 Global Top Manufacturers Dolutegravir/Rilpivirine Combination Drug Manufacturing Base Distribution, Sales Area, Product Type 2.5 Dolutegravir/Rilpivirine Combination Drug Market Competitive Situation and Trends 2.5.1 Dolutegravir/Rilpivirine Combination Drug Market Concentration Rate (2016-2021) 2.5.2 Global 5 and 10 Largest Manufacturers by Dolutegravir/Rilpivirine Combination Drug Sales and Revenue in 2020 2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Dolutegravir/Rilpivirine Combination Drug as of 2020) 2.7 Date of Key Manufacturers Enter into Dolutegravir/Rilpivirine Combination Drug Market 2.8 Key Manufacturers Dolutegravir/Rilpivirine Combination Drug Product Offered 2.9 Mergers & Acquisitions, Expansion 3 Dolutegravir/Rilpivirine Combination Drug Status and Outlook by Region 3.1 Global Dolutegravir/Rilpivirine Combination Drug Market Size and CAGR by Region: 2016 VS 2021 VS 2026 3.2 Global Dolutegravir/Rilpivirine Combination Drug Historic Market Size by Region 3.2.1 Global Dolutegravir/Rilpivirine Combination Drug Sales in Volume by Region (2016-2021) 3.2.2 Global Dolutegravir/Rilpivirine Combination Drug Sales in Value by Region (2016-2021) 3.2.3 Global Dolutegravir/Rilpivirine Combination Drug Sales (Volume & Value) Price and Gross Margin (2016-2021) 3.3 Global Dolutegravir/Rilpivirine Combination Drug Forecasted Market Size by Region 3.3.1 Global Dolutegravir/Rilpivirine Combination Drug Sales in Volume by Region (2022-2027) 3.3.2 Global Dolutegravir/Rilpivirine Combination Drug Sales in Value by Region (2022-2027) 3.3.3 Global Dolutegravir/Rilpivirine Combination Drug Sales (Volume & Value), Price and Gross Margin (2022-2027) 4 Global Dolutegravir/Rilpivirine Combination Drug by Application 4.1 Dolutegravir/Rilpivirine Combination Drug Market Segment by Application 4.1.1 Hospital 4.1.2 Clinic 4.1.3 Drug Center 4.1.4 Other 4.2 Global Dolutegravir/Rilpivirine Combination Drug Market Size by Application 4.2.1 Global Dolutegravir/Rilpivirine Combination Drug Market Size Overview by Application (2016-2027) 4.2.2 Global Dolutegravir/Rilpivirine Combination Drug Historic Market Size Review by Application (2016-2021) 4.2.2.1 Global Dolutegravir/Rilpivirine Combination Drug Sales Breakdown in Volume, by Application (2016-2021) 4.2.2.2 Global Dolutegravir/Rilpivirine Combination Drug Sales Breakdown in Value, by Application (2016-2021) 4.2.2.3 Global Dolutegravir/Rilpivirine Combination Drug Average Selling Price (ASP) by Application (2016-2021) 4.2.3 Global Dolutegravir/Rilpivirine Combination Drug Forecasted Market Size by Application (2022-2027) 4.2.3.1 Global Dolutegravir/Rilpivirine Combination Drug Sales Breakdown in Volume, by Application (2022-2027) 4.2.3.2 Global Dolutegravir/Rilpivirine Combination Drug Sales Breakdown in Value, by Application (2022-2027) 4.2.3.3 Global Dolutegravir/Rilpivirine Combination Drug Average Selling Price (ASP) by Application (2022-2027) 4.3 Key Regions Market Size Segment by Application 4.3.1 North America Dolutegravir/Rilpivirine Combination Drug Sales Breakdown by Application (2016-2021) 4.3.2 Europe Dolutegravir/Rilpivirine Combination Drug Sales Breakdown by Application (2016-2021) 4.3.3 Asia-Pacific Dolutegravir/Rilpivirine Combination Drug Sales Breakdown by Application (2016-2021) 4.3.4 Latin America Dolutegravir/Rilpivirine Combination Drug Sales Breakdown by Application (2016-2021) 4.3.5 Middle East and Africa Dolutegravir/Rilpivirine Combination Drug Sales Breakdown by Application (2016-2021) 5 North America Dolutegravir/Rilpivirine Combination Drug by Country 5.1 North America Dolutegravir/Rilpivirine Combination Drug Historic Market Size by Country 5.1.1 North America Dolutegravir/Rilpivirine Combination Drug Sales in Volume by Country (2016-2021) 5.1.2 North America Dolutegravir/Rilpivirine Combination Drug Sales in Value by Country (2016-2021) 5.2 North America Dolutegravir/Rilpivirine Combination Drug Forecasted Market Size by Country 5.2.1 North America Dolutegravir/Rilpivirine Combination Drug Sales in Volume by Country (2022-2027) 5.2.2 North America Dolutegravir/Rilpivirine Combination Drug Sales in Value by Country (2022-2027) 6 Europe Dolutegravir/Rilpivirine Combination Drug by Country 6.1 Europe Dolutegravir/Rilpivirine Combination Drug Historic Market Size by Country 6.1.1 Europe Dolutegravir/Rilpivirine Combination Drug Sales in Volume by Country (2016-2021) 6.1.2 Europe Dolutegravir/Rilpivirine Combination Drug Sales in Value by Country (2016-2021) 6.2 Europe Dolutegravir/Rilpivirine Combination Drug Forecasted Market Size by Country 6.2.1 Europe Dolutegravir/Rilpivirine Combination Drug Sales in Volume by Country (2022-2027) 6.2.2 Europe Dolutegravir/Rilpivirine Combination Drug Sales in Value by Country (2022-2027) 7 Asia-Pacific Dolutegravir/Rilpivirine Combination Drug by Region 7.1 Asia-Pacific Dolutegravir/Rilpivirine Combination Drug Historic Market Size by Region 7.1.1 Asia-Pacific Dolutegravir/Rilpivirine Combination Drug Sales in Volume by Region (2016-2021) 7.1.2 Asia-Pacific Dolutegravir/Rilpivirine Combination Drug Sales in Value by Region (2016-2021) 7.2 Asia-Pacific Dolutegravir/Rilpivirine Combination Drug Forecasted Market Size by Region 7.2.1 Asia-Pacific Dolutegravir/Rilpivirine Combination Drug Sales in Volume by Region (2022-2027) 7.2.2 Asia-Pacific Dolutegravir/Rilpivirine Combination Drug Sales in Value by Region (2022-2027) 8 Latin America Dolutegravir/Rilpivirine Combination Drug by Country 8.1 Latin America Dolutegravir/Rilpivirine Combination Drug Historic Market Size by Country 8.1.1 Latin America Dolutegravir/Rilpivirine Combination Drug Sales in Volume by Country (2016-2021) 8.1.2 Latin America Dolutegravir/Rilpivirine Combination Drug Sales in Value by Country (2016-2021) 8.2 Latin America Dolutegravir/Rilpivirine Combination Drug Forecasted Market Size by Country 8.2.1 Latin America Dolutegravir/Rilpivirine Combination Drug Sales in Volume by Country (2022-2027) 8.2.2 Latin America Dolutegravir/Rilpivirine Combination Drug Sales in Value by Country (2022-2027) 9 Middle East and Africa Dolutegravir/Rilpivirine Combination Drug by Country 9.1 Middle East and Africa Dolutegravir/Rilpivirine Combination Drug Historic Market Size by Country 9.1.1 Middle East and Africa Dolutegravir/Rilpivirine Combination Drug Sales in Volume by Country (2016-2021) 9.1.2 Middle East and Africa Dolutegravir/Rilpivirine Combination Drug Sales in Value by Country (2016-2021) 9.2 Middle East and Africa Dolutegravir/Rilpivirine Combination Drug Forecasted Market Size by Country 9.2.1 Middle East and Africa Dolutegravir/Rilpivirine Combination Drug Sales in Volume by Country (2022-2027) 9.2.2 Middle East and Africa Dolutegravir/Rilpivirine Combination Drug Sales in Value by Country (2022-2027) 10 Company Profiles and Key Figures in Dolutegravir/Rilpivirine Combination Drug Business 10.1 ViiV Healthcare 10.1.1 ViiV Healthcare Corporation Information 10.1.2 ViiV Healthcare Introduction and Business Overview 10.1.3 ViiV Healthcare Dolutegravir/Rilpivirine Combination Drug Sales, Revenue and Gross Margin (2016-2021) 10.1.4 ViiV Healthcare Dolutegravir/Rilpivirine Combination Drug Products Offered 10.1.5 ViiV Healthcare Recent Development 10.2 JNJ 10.2.1 JNJ Corporation Information 10.2.2 JNJ Introduction and Business Overview 10.2.3 JNJ Dolutegravir/Rilpivirine Combination Drug Sales, Revenue and Gross Margin (2016-2021) 10.2.4 ViiV Healthcare Dolutegravir/Rilpivirine Combination Drug Products Offered 10.2.5 JNJ Recent Development 11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis 11.1 Dolutegravir/Rilpivirine Combination Drug Key Raw Materials 11.1.1 Key Raw Materials 11.1.2 Key Raw Materials Price 11.1.3 Raw Materials Key Suppliers 11.2 Manufacturing Cost Structure 11.2.1 Raw Materials 11.2.2 Labor Cost 11.2.3 Manufacturing Expenses 11.3 Dolutegravir/Rilpivirine Combination Drug Industrial Chain Analysis 11.4 Dolutegravir/Rilpivirine Combination Drug Market Dynamics 11.4.1 Industry Trends 11.4.2 Market Drivers 11.4.3 Market Challenges 11.4.4 Market Restraints 12 Market Strategy Analysis, Distributors 12.1 Sales Channel 12.2 Dolutegravir/Rilpivirine Combination Drug Distributors 12.3 Dolutegravir/Rilpivirine Combination Drug Downstream Customers 13 Research Findings and Conclusion 14 Appendix 14.1 Research Methodology 14.1.1 Methodology/Research Approach 14.1.1.1 Research Programs/Design 14.1.1.2 Market Size Estimation 14.1.1.3 Market Breakdown and Data Triangulation 14.1.2 Data Source 14.1.2.1 Secondary Sources 14.1.2.2 Primary Sources 14.2 Author Details 14.3 Disclaimer

List of Tables Table 1. Major Company of Self-production API Table 2. Major Company of Outsourcing of API Table 3. Global Dolutegravir/Rilpivirine Combination Drug Sales by Type 2016 VS 2021 VS 2027 (US$ Million) Table 4. Global Dolutegravir/Rilpivirine Combination Drug Sales by Type (2016-2021) & (K Pcs) Table 5. Global Dolutegravir/Rilpivirine Combination Drug Sales Market Share in Volume by Type (2016-2021) Table 6. Global Dolutegravir/Rilpivirine Combination Drug Sales by Type (2016-2021) & (US& Million) Table 7. Global Dolutegravir/Rilpivirine Combination Drug Market Share in Value by Type (2016-2021) Table 8. Global Dolutegravir/Rilpivirine Combination Drug Price by Type (2016-2021) & (USD/Pcs) Table 9. Global Dolutegravir/Rilpivirine Combination Drug Sales by Type (2022-2027) & (K Pcs) Table 10. Global Dolutegravir/Rilpivirine Combination Drug Sales Market Share in Volume by Type (2022-2027) Table 11. Global Dolutegravir/Rilpivirine Combination Drug Sales by Type (2022-2027) & (US$ Million) Table 12. Global Dolutegravir/Rilpivirine Combination Drug Sales Market Share in Value by Type (2022-2027) Table 13. Global Dolutegravir/Rilpivirine Combination Drug Price by Type (2022-2027) & (USD/Pcs) Table 14. North America Dolutegravir/Rilpivirine Combination Drug Sales by Type (2016-2021) & (K Pcs) Table 15. North America Dolutegravir/Rilpivirine Combination Drug Sales by Type (2016-2021) & (US$ Million) Table 16. Europe Dolutegravir/Rilpivirine Combination Drug Sales (K Pcs) by Type (2016-2021) Table 17. Europe Dolutegravir/Rilpivirine Combination Drug Sales by Type (2016-2021) & (US$ Million) Table 18. Asia-Pacific Dolutegravir/Rilpivirine Combination Drug Sales (K Pcs) by Type (2016-2021) Table 19. Asia-Pacific Dolutegravir/Rilpivirine Combination Drug Sales by Type (2016-2021) & (US$ Million) Table 20. Latin America Dolutegravir/Rilpivirine Combination Drug Sales (K Pcs) by Type (2016-2021) Table 21. Latin America Dolutegravir/Rilpivirine Combination Drug Sales by Type (2016-2021) & (US$ Million) Table 22. Middle East and Africa Dolutegravir/Rilpivirine Combination Drug Sales (K Pcs) by Type (2016-2021) Table 23. Middle East and Africa Dolutegravir/Rilpivirine Combination Drug Sales by Type (2016-2021) & (US$ Million) Table 24. Global Dolutegravir/Rilpivirine Combination Drug Sales by Company (2016-2021) & (K Pcs) Table 25. Global Dolutegravir/Rilpivirine Combination Drug Sales Share by Company (2016-2021) Table 26. Global Dolutegravir/Rilpivirine Combination Drug Revenue by Company (2016-2021) & (US$ Million) Table 27. Global Dolutegravir/Rilpivirine Combination Drug Revenue Share by Company (2016-2021) Table 28. Global Market Dolutegravir/Rilpivirine Combination Drug Price by Company (2016-2021) & (USD/Pcs) Table 29. Global Dolutegravir/Rilpivirine Combination Drug Top Manufacturers Manufacturing Base Distribution and Sales Area Table 30. Global Dolutegravir/Rilpivirine Combination Drug Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Dolutegravir/Rilpivirine Combination Drug as of 2020 Table 32. Date of Key Manufacturers Enter into Dolutegravir/Rilpivirine Combination Drug Market Table 33. Key Manufacturers Dolutegravir/Rilpivirine Combination Drug Product Type Table 34. Mergers & Acquisitions, Expansion Plans Table 35. Global Dolutegravir/Rilpivirine Combination Drug Market Size Comparison by Region (US$ Million): 2016 VS 2021 VS 2027 Table 36. Global Dolutegravir/Rilpivirine Combination Drug Sales by Region (2016-2021) & (K Pcs) Table 37. Global Dolutegravir/Rilpivirine Combination Drug Sales Market Share in Volume by Region (2016-2021) Table 38. Global Dolutegravir/Rilpivirine Combination Drug Sales by Region (2016-2021) & (US$ Million) Table 39. Global Dolutegravir/Rilpivirine Combination Drug Sales Market Share in Value by Region (2016-2021) Table 40. Global Dolutegravir/Rilpivirine Combination Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021) Table 41. Global Dolutegravir/Rilpivirine Combination Drug Sales by Region (2022-2027) & (K Pcs) Table 42. Global Dolutegravir/Rilpivirine Combination Drug Sales Market Share in Volume by Region (2022-2027) Table 43. Global Dolutegravir/Rilpivirine Combination Drug Sales by Region (2022-2027) & (US$ Million) Table 44. Global Dolutegravir/Rilpivirine Combination Drug Sales Market Share in Value by Region (2022-2027) Table 45. Global Dolutegravir/Rilpivirine Combination Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2022-2027) Table 46. Global Dolutegravir/Rilpivirine Combination Drug Sales by Application: 2016 VS 2021 VS 2027 (US$ Million) Table 47. Global Dolutegravir/Rilpivirine Combination Drug Sales by Application (2016-2021) & (K Pcs) Table 48. Global Dolutegravir/Rilpivirine Combination Drug Sales Market Share in Volume by Application (2016-2021) Table 49. Global Dolutegravir/Rilpivirine Combination Drug Sales by Application (2016-2021) & (US$ Million) Table 50. Global Dolutegravir/Rilpivirine Combination Drug Sales Market Share in Value by Application (2016-2021) Table 51. Global Dolutegravir/Rilpivirine Combination Drug Price by Application (2016-2021) & (USD/Pcs) Table 52. Global Dolutegravir/Rilpivirine Combination Drug Sales by Application (2022-2027) & (K Pcs) Table 53. Global Dolutegravir/Rilpivirine Combination Drug Sales Market Share in Volume by Application (2022-2027) Table 54. Global Dolutegravir/Rilpivirine Combination Drug Sales by Application (2022-2027) & (US$ Million) Table 55. Global Dolutegravir/Rilpivirine Combination Drug Sales Market Share in Value by Application (2022-2027) Table 56. Global Dolutegravir/Rilpivirine Combination Drug Price by Application (2022-2027) & (USD/Pcs) Table 57. North America Dolutegravir/Rilpivirine Combination Drug Sales by Application (2016-2021) (K Pcs) Table 58. North America Dolutegravir/Rilpivirine Combination Drug Sales by Application (2016-2021) & (US$ Million) Table 59. North America Dolutegravir/Rilpivirine Combination Drug Sales Market Share in Value by Application in 2020 Table 60. Europe Dolutegravir/Rilpivirine Combination Drug Sales by Application (2016-2021) (K Pcs) Table 61. Europe Dolutegravir/Rilpivirine Combination Drug Sales by Application (2016-2021) & (US$ Million) Table 62. Europe Dolutegravir/Rilpivirine Combination Drug Sales Market Share in Value by Application in 2020 Table 63. Asia-Pacific Dolutegravir/Rilpivirine Combination Drug Sales by Application (2016-2021) (K Pcs) Table 64. Asia-Pacific Dolutegravir/Rilpivirine Combination Drug Sales by Application (2016-2021) & (US$ Million) Table 65. Asia-Pacific Dolutegravir/Rilpivirine Combination Drug Sales Market Share in Value by Application in 2020 Table 66. Latin America Dolutegravir/Rilpivirine Combination Drug Sales by Application (2016-2021) (K Pcs) Table 67. Latin America Dolutegravir/Rilpivirine Combination Drug Sales by Application (2016-2021) & (US$ Million) Table 68. Latin America Dolutegravir/Rilpivirine Combination Drug Sales Market Share in Value by Application in 2020 Table 69. Middle East and Africa Dolutegravir/Rilpivirine Combination Drug Sales by Application (2016-2021) (K Pcs) Table 70. Middle East and Africa Dolutegravir/Rilpivirine Combination Drug Sales by Application (2016-2021) & (US$ Million) Table 71. Middle East and Africa Dolutegravir/Rilpivirine Combination Drug Sales Market Share in Value by Application in 2020 Table 72. North America Dolutegravir/Rilpivirine Combination Drug Sales by Country (2016-2021) & (K Pcs) Table 73. North America Dolutegravir/Rilpivirine Combination Drug Sales Market Share in Volume by Country (2016-2021) Table 74. North America Dolutegravir/Rilpivirine Combination Drug Sales by Country (2016-2021) & (US$ Million) Table 75. North America Dolutegravir/Rilpivirine Combination Drug Sales Market Share in Value by Country (2016-2021) Table 76. North America Dolutegravir/Rilpivirine Combination Drug Sales by Country (2022-2027) & (K Pcs) Table 77. North America Dolutegravir/Rilpivirine Combination Drug Sales Market Share in Volume by Country (2022-2027) Table 78. North America Dolutegravir/Rilpivirine Combination Drug Sales by Country (2022-2027) & (US$ Million) Table 79. North America Dolutegravir/Rilpivirine Combination Drug Sales Market Share in Value by Country (2022-2027) Table 80. Europe Dolutegravir/Rilpivirine Combination Drug Sales by Country (2016-2021) & (K Pcs) Table 81. Europe Dolutegravir/Rilpivirine Combination Drug Sales Market Share in Volume by Country (2016-2021) Table 82. Europe Dolutegravir/Rilpivirine Combination Drug Sales by Country (2016-2021) & (US$ Million) Table 83. Europe Dolutegravir/Rilpivirine Combination Drug Sales Market Share in Value by Country (2016-2021) Table 84. Europe Dolutegravir/Rilpivirine Combination Drug Sales by Country (2022-2027) & (K Pcs) Table 85. Europe Dolutegravir/Rilpivirine Combination Drug Sales Market Share in Volume by Country (2022-2027) Table 86. Europe Dolutegravir/Rilpivirine Combination Drug Sales by Country (2022-2027) & (US$ Million) Table 87. Europe Dolutegravir/Rilpivirine Combination Drug Sales Market Share in Value by Country (2022-2027) Table 88. Asia-Pacific Dolutegravir/Rilpivirine Combination Drug Sales by Region (2016-2021) & (K Pcs) Table 89. Asia-Pacific Dolutegravir/Rilpivirine Combination Drug Sales Market Share in Volume by Region (2016-2021) Table 90. Asia-Pacific Dolutegravir/Rilpivirine Combination Drug Sales by Region (2016-2021) & (US$ Million) Table 91. Asia-Pacific Dolutegravir/Rilpivirine Combination Drug Sales Market Share in Value by Region (2016-2021) Table 92. Asia-Pacific Dolutegravir/Rilpivirine Combination Drug Sales by Region (2022-2027) & (K Pcs) Table 93. Asia-Pacific Dolutegravir/Rilpivirine Combination Drug Sales Market Share in Volume by Region (2022-2027) Table 94. Asia-Pacific Dolutegravir/Rilpivirine Combination Drug Sales by Region (2022-2027) & (US$ Million) Table 95. Asia-Pacific Dolutegravir/Rilpivirine Combination Drug Sales Market Share in Value by Region (2022-2027) Table 96. Latin America Dolutegravir/Rilpivirine Combination Drug Sales by Country (2016-2021) & (K Pcs) Table 97. Latin America Dolutegravir/Rilpivirine Combination Drug Sales Market Share in Volume by Country (2016-2021) Table 98. Latin America Dolutegravir/Rilpivirine Combination Drug Sales by Country (2016-2021) & (US$ Million) Table 99. Latin America Dolutegravir/Rilpivirine Combination Drug Sales Market Share in Value by Country (2016-2021) Table 100. Latin America Dolutegravir/Rilpivirine Combination Drug Sales by Country (2022-2027) & (K Pcs) Table 101. Latin America Dolutegravir/Rilpivirine Combination Drug Sales Market Share in Volume by Country (2022-2027) Table 102. Latin America Dolutegravir/Rilpivirine Combination Drug Sales by Country (2022-2027) & (US$ Million) Table 103. Latin America Dolutegravir/Rilpivirine Combination Drug Sales Market Share in Value by Country (2022-2027) Table 104. Middle East and Africa Dolutegravir/Rilpivirine Combination Drug Sales by Country (2016-2021) & (K Pcs) Table 105. Middle East and Africa Dolutegravir/Rilpivirine Combination Drug Sales Market Share in Volume by Country (2016-2021) Table 106. Middle East and Africa Dolutegravir/Rilpivirine Combination Drug Sales by Country (2016-2021) & (US$ Million) Table 107. Middle East and Africa Dolutegravir/Rilpivirine Combination Drug Sales Market Share in Value by Country (2016-2021) Table 108. Middle East and Africa Dolutegravir/Rilpivirine Combination Drug Sales by Country (2022-2027) & (K Pcs) Table 109. Middle East and Africa Dolutegravir/Rilpivirine Combination Drug Sales Market Share in Volume by Country (2022-2027) Table 110. Middle East and Africa Dolutegravir/Rilpivirine Combination Drug Sales by Country (2022-2027) & (US$ Million) Table 111. Middle East and Africa Dolutegravir/Rilpivirine Combination Drug Sales Market Share in Value by Country (2022-2027) Table 112. ViiV Healthcare Corporation Information Table 113. ViiV Healthcare Introduction and Business Overview Table 114. ViiV Healthcare Dolutegravir/Rilpivirine Combination Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 115. ViiV Healthcare Dolutegravir/Rilpivirine Combination Drug Product Table 116. ViiV Healthcare Recent Development Table 117. JNJ Corporation Information Table 118. JNJ Introduction and Business Overview Table 119. JNJ Dolutegravir/Rilpivirine Combination Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 120. JNJ Dolutegravir/Rilpivirine Combination Drug Product Table 121. JNJ Recent Development Table 122. Key Raw Materials Lists Table 123. Raw Materials Key Suppliers Lists Table 124. Dolutegravir/Rilpivirine Combination Drug Market Trends Table 125. Dolutegravir/Rilpivirine Combination Drug Market Drivers Table 126. Dolutegravir/Rilpivirine Combination Drug Market Challenges Table 127. Dolutegravir/Rilpivirine Combination Drug Market Restraints Table 128. Dolutegravir/Rilpivirine Combination Drug Distributors List Table 129. Dolutegravir/Rilpivirine Combination Drug Downstream Customers Table 130. Research Programs/Design for This Report Table 131. Key Data Information from Secondary Sources Table 132. Key Data Information from Primary Sources List of Figures Figure 1. Dolutegravir/Rilpivirine Combination Drug Product Picture Figure 2. Global Dolutegravir/Rilpivirine Combination Drug Market Size, 2016 VS 2021 VS 2027 (US$ Million) Figure 3. Global Dolutegravir/Rilpivirine Combination Drug Market Size Status and Outlook (2016-2027) & (US$ Million) Figure 4. Global Dolutegravir/Rilpivirine Combination Drug Sales Status and Outlook (2016-2027) & (K Pcs) Figure 5. Product Picture of Self-production API Figure 6. Global Self-production API Sales YoY Growth (2016-2021) & (K Pcs) Figure 7. Product Picture of Outsourcing of API Figure 8. Global Outsourcing of API Sales YoY Growth (2016-2021) & (K Pcs) Figure 9. Global Dolutegravir/Rilpivirine Combination Drug Sales by Type (2016-2027) & (US$ Million) Figure 10. Global Dolutegravir/Rilpivirine Combination Drug Sales Market Share in Volume by Type (2016-2021) Figure 11. Global Dolutegravir/Rilpivirine Combination Drug Sales Market Share in Value by Type (2016-2021) Figure 12. Global Dolutegravir/Rilpivirine Combination Drug Sales Market Share in Volume by Type (2022-2027) Figure 13. Global Dolutegravir/Rilpivirine Combination Drug Sales Market Share in Value by Type (2022-2027) Figure 14. North America Dolutegravir/Rilpivirine Combination Drug Sales Market Share in Volume by Type in 2020 Figure 15. North America Dolutegravir/Rilpivirine Combination Drug Sales Market Share in Value by Type in 2020 Figure 16. Europe Dolutegravir/Rilpivirine Combination Drug Sales Market Share in Volume by Type in 2020 Figure 17. Europe Dolutegravir/Rilpivirine Combination Drug Sales Market Share in Value by Type in 2020 Figure 18. Asia-Pacific Dolutegravir/Rilpivirine Combination Drug Sales Market Share in Volume by Type in 2020 Figure 19. Asia-Pacific Dolutegravir/Rilpivirine Combination Drug Sales Market Share in Value by Type in 2020 Figure 20. Latin America Dolutegravir/Rilpivirine Combination Drug Sales Market Share in Volume by Type in 2020 Figure 21. Latin America Dolutegravir/Rilpivirine Combination Drug Sales Market Share in Value by Type in 2020 Figure 22. Middle East and Africa Dolutegravir/Rilpivirine Combination Drug Sales Market Share in Volume by Type in 2020 Figure 23. Middle East and Africa Dolutegravir/Rilpivirine Combination Drug Sales Market Share in Value by Type in 2020 Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Dolutegravir/Rilpivirine Combination Drug Sales in 2020 Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Dolutegravir/Rilpivirine Combination Drug Revenue in 2020 Figure 26. Dolutegravir/Rilpivirine Combination Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020 Figure 27. Product Picture of Hospital Figure 28. Global Hospital Sales YoY Growth (2016-2027) & (K Pcs) Figure 29. Product Picture of Clinic Figure 30. Global Clinic Sales YoY Growth (2016-2027) & (K Pcs) Figure 31. Product Picture of Drug Center Figure 32. Global Drug Center Sales YoY Growth (2016-2027) & (K Pcs) Figure 33. Product Picture of Other Figure 34. Global Other Sales YoY Growth (2016-2027) & (K Pcs) Figure 35. Global Dolutegravir/Rilpivirine Combination Drug Sales by Application (2016-2027) & (US$ Million) Figure 36. Global Dolutegravir/Rilpivirine Combination Drug Sales Market Share in Volume by Application (2016-2021) Figure 37. Global Dolutegravir/Rilpivirine Combination Drug Sales Market Share in Value by Application (2016-2021) Figure 38. Global Dolutegravir/Rilpivirine Combination Drug Sales Market Share in Volume by Application (2022-2027) Figure 39. North America Dolutegravir/Rilpivirine Combination Drug Sales Market Share in Volume by Application in 2020 Figure 40. Latin America Dolutegravir/Rilpivirine Combination Drug Sales Market Share in Value by Application in 2020 Figure 41. Middle East and Africa Dolutegravir/Rilpivirine Combination Drug Sales Market Share in Value by Application in 2020 Figure 42. Key Raw Materials Price Figure 43. Dolutegravir/Rilpivirine Combination Drug Manufacturing Cost Structure Figure 44. Dolutegravir/Rilpivirine Combination Drug Industrial Chain Analysis Figure 45. Channels of Distribution Figure 46. Distributors Profiles Figure 47. Bottom-up and Top-down Approaches for This Report Figure 48. Data Triangulation Figure 49. Key Executives Interviewed

ViiV Healthcare JNJ